IAM
NXTM

Iridian Asset Management’s NxStage Medical Inc. NXTM Stock Holding History

Iridian Asset Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-18,730
Closed -$267K – 140
2013
Q2 		$267K Buy
+18,730
New +$236K ﹤0.01% 119

Other funds holding NXTM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Iridian Asset Management's NXTM Position: Q3 2013 in Review

Iridian Asset Management sold out of NxStage Medical Inc. (NXTM) in Q3 2013, closing a stake of 18,730 shares — an estimated $267K sold.

Iridian Asset Management first reported a position in NXTM in Q2 2013 and held it in 1 quarter. The position peaked at $267K in Q2 2013. 115 funds tracked by Wall St. Rank hold NXTM as of Q3 2013.

  • Iridian Asset Management reported no remaining NxStage Medical Inc. position as of Q3 2013 after selling out during the quarter.
  • Iridian Asset Management sold 18,730 NxStage Medical Inc. shares in Q3 2013, an estimated $267K.
  • Iridian Asset Management first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 1 quarter.
  • Iridian Asset Management's NxStage Medical Inc. position peaked at $267K in Q2 2013.
  • 115 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2013.

Based on Iridian Asset Management's 13F filing for Q3 2013, filed 12 Nov 2013.